Pangea Botanica
Develops TrkB-activating drug candidates for central nervous system disorders
Highlights
- New on EvolcAdded 2026-11-11
About Pangea Botanica
Pangea Botanica is a clinical-stage biotechnology company developing therapeutics intended to promote neuronal survival and synaptic plasticity by activating the TrkB receptor pathway. Its pipeline includes lead candidate OT-003 and the OT-1xx series, with a focus on neurological and mental health disorders.
The company is based in Sevenoaks, United Kingdom, and presents an office in London. Its lead candidate has received Clinical Trial Authorization.
Product: Drug discovery and development focused on TrkB-activating therapeutics for central nervous system disorders.
Jobs at Pangea Botanica
Leadership
- Julia Wilde · Co-Founder & Chief People and Impact OfficerSource: company website
- Manon Veraart · Co-Founder & Chief Business OfficerSource: company website
- Thomas Pfeiffer · Co-Founder & Senior Vice President of Research and DevelopmentSource: company website
- Lars Wilde · Co-Founder & Chief Executive OfficerSource: company website
More biotech & pharma companies
Particology
Contract particle science and solid form services for pharma teams taking small-molecule drugs to formulated productsYoung companyNew on EvolcPathios Therapeutics
Develops GPR65-targeting cancer immunotherapies for patients with solid tumorsNew on EvolcPencil Biosciences
Synthetic gene-editing technology for therapeutic development and cell-line engineeringNew on EvolcPentabind
AI-designed aptamers and molecular discovery services for biotech, diagnostics and therapeutics partnersYoung companyNew on EvolcPeptimatrix
Synthetic peptide hydrogels for 3D cell culture used by pharmaceutical, biotechnology and academic researchersYoung companyNew on EvolcPeptone
Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targets
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4Medium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- IubendaHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- BambooHRMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.